HEAD AND NECK CANCERS - THROAT
Clinical trials for HEAD AND NECK CANCERS - THROAT explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCERS - THROAT trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCERS - THROAT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat head and neck cancers
Disease control Recruiting nowThis early-stage trial is testing a new combination of two experimental drugs, tislelizumab and pamiparib, given together with a standard course of chemotherapy and radiation. The goal is to find a safe and effective dose for people whose head and neck cancer has come back after …
Matched conditions: HEAD AND NECK CANCERS - THROAT
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New pill targets tough cancers after other treatments fail
Disease control Recruiting nowThis early-stage study is testing a new oral drug called VMD-928, both by itself and combined with an existing immunotherapy (pembrolizumab). It is for adults with advanced solid tumors or lymphoma that have progressed despite available treatments. The main goals are to find safe…
Matched conditions: HEAD AND NECK CANCERS - THROAT
Phase: PHASE1, PHASE2 • Sponsor: VM Oncology, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC